Dec 3, 2021

Male Adenoid Cystic Carcinoma of the Breast 
By Jie Xiao Li et al. Journal of Medical Cases, Vol. 12, No. 12, Dec 2021

Adenoid cystic carcinoma (ACC) of the breast, a rare malignancy that makes up less than 0.1% of all breast malignancies, is much rarer in males than in females. Due to the rarity of this disease, an optimal treatment strategy for male breast ACC has not been established, and therapy for male patients is currently based on guidelines for female patients. According to previous reported cases, some authors believe that male breast ACC may have higher invasive potential than female breast ACC and the prognoses in male patients may be worse than those in female patients.  Read More.... 
 

Nov 18, 2021
Genetic Polymorphisms in Pharmaceuticals and Chemotherapy 
By Aneesha Choudary Gummadi et al. World Journal of Oncology, Vol. 12, No. 5, Oct 2021

The study of genetic polymorphisms has significantly advanced the field of personalized medicine. Polymorphism of genes influence the efficacy of drugs used for treating medical conditions such as depression, cardiac diseases, thromboembolic disorders, oncological diseases, etc. The study of genetic polymorphism is beneficial for drug safety as well as for assessing therapeutic outcomes.  Read More.... 

Let's Combat COVID-19 Together.
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and healthcare givers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.  For more information, please contact production@elmerpress.com or the individual journal's editor.
View our published articles on COVID-19